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I. Antibodies and reagents
The following primary antibodies were used: mouse monoclonal antibodies against Parkin (Santa Cruz), βI-tubulin (Sigma), β-actin (Sigma), GAPDH (Santa Cruz), PSD95 (Cell Signaling), synaptophysin (cell signalling), CISD1 (Proteintech). Horseradish-peroxidase (HRP)-conjugated secondary antibodies (Sigma) were used. Anti-Parkin phospho-Ser65 rabbit monoclonal antibody was raised by Epitomics in collaboration with the Michael J Fox Foundation for Research. Stock solutions of niclosamide (Sigma), Antimycin A (Sigma) Oligomycin A (Sigma) were used for experiments in vitro. Unless otherwise specified, general reagents and chemicals were from Sigma and cell culture reagents were from Invitrogen.
II. Cell culture
HeLa cells stably expressing untagged Parkin WT and PINK 1 KO, were cultured using DMEM (Dulbecco's modified Eagle's medium) supplemented with 10% FBS, 2 mM Lglutamine, 1×penicillin/streptomycin. To uncouple mitochondria, cells were treated with 10 µM Antimycin (Sigma) and 1 µM Oligomycin dissolved in DMSO for 3 h. To express Parkin, cell transfections were performed using polyethylenimine (Polysciences) according to the manufacturer's instruction. Primary cortical neurons were isolated from the brain of WT embryos of either sex at E16.5. Embryonic cortices were collected in HBSS, and cells were dissociated by incubation with trypsin (GIBCO) at 37°C. Cells were then diluted in Neurobasal medium containing B27 supplement, Glutamax, penicillin/streptomycin and plated at a density of 6.0 × 106 cells/well on 6-well plates coated with 0.1 mg/ml poly-L-lysine (PLL; Sigma). Neurons were cultured at 37 °C in a humidified incubator with 5% CO 2 . Every 7 days, the medium was replaced with fresh medium containing B27. Neurons were treated with 30 µM niclosamide and analogues for 1h at 37 °C.
III. Synthesis of AM85-AM87 compounds
To a stirring solution of the relevant salicylic acid (1 eq.) in dry THF, PyBop (1.2 eq.) and triethylamine (3 eq.) were added. After 10 min, the relevant aniline (1.5 eq.) was added to the cloudy white suspension and stirred at room temperature for 12 h. The reaction mixture was then concentrated under reduced pressure to afford a yellow oil, which was subsequently dissolved in water and extracted in ethyl acetate. The combined organic layers were dried (MgSO 4 ), filtered and concentrated under reduced pressure to form a viscous orange oil. Flash column chromatography employing ethyl acetate:hexane (1:1) was used to yield the desired AM compounds as off-white solids. 18, 156.98, 138.91, 137.87, 130.26, 129.21, 125.40, 122.23, 118.88, 113.14, 109.71 
5-Bromo-N-(4-bromophenyl)-2-hydroxybenzamide (AM85
